Private healthcare boosts its presence

Private healthcare boosts its presence

Together with expansion plans among foreign-invested enterprises, emerging private players are boosting their presence in the promising local healthcare market.
Bayer unveils medical breakthroughs

Bayer unveils medical breakthroughs

Bayer is set to embark on its next phase of growth with a new wave of medical breakthroughs.
Vietnam Minister of Planning and Investment visits AstraZeneca China

Vietnam Minister of Planning and Investment visits AstraZeneca China

A delegation led by Minister for Planning and Investment Nguyen Chi Dung has visited the AstraZeneca Global (R&D) China Centre.
Healthcare service quality must meet global standards

Healthcare service quality must meet global standards

Vietnam is actively improving the quality of medical services at hospitals towards meeting international standards, aiming to engage foreigners for medical examination and treatment here.
Innovation and teamwork will address strain in health

Innovation and teamwork will address strain in health

By constantly bringing breakthrough innovations to market, Siemens Healthineers enable healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. Vy Tran, president of Siemens Healthineers Asia-Pacific and Japan, talked with VIR’s Bich Ngoc about the innovation and collaborations keeping the company in the lead.
Healthcare models for sustainability era

Healthcare models for sustainability era

The health sector had a busy 2023, with many important foundations laid to strengthen the quality, resilience, and sustainability into the future.
Increasing private investment in healthcare – A long journey ahead

Increasing private investment in healthcare – A long journey ahead

While making efforts to attract investment, the healthcare sector yet to meet its expectations. Nguyen Thi Lien Huong, Deputy Minister of Health, talked with VIR’s Bich Thuy the next steps ahead to make improvements.
AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam has started the year by building on last year’s success with programmes that cater to improving livelihoods and enhancing healthcare.
A more conducive environment needed for investors

A more conducive environment needed for investors

Last year marked Pharma Group’s 25-year journey of partnership in Vietnam. That year was even more significant for healthcare as we have witnessed several key laws issued with great improvements, notably the Law on Bidding and the Law on Medical Examination and Treatment.
AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca Vietnam and the Vietnam Young Physicians Association have signed an MoU on future cooperation.
WHO weighs up AI risks and benefits for healthcare

WHO weighs up AI risks and benefits for healthcare

Generative artificial intelligence could transform healthcare through things like drug development and quicker diagnoses, but the World Health Organization warned Thursday of the potential pitfalls in rushing to embrace AI.
Alina Vision secures investment from TVM Capital Healthcare

Alina Vision secures investment from TVM Capital Healthcare

Alina Vision has secured a significant investment from Singapore's TVM Capital Healthcare to help accelerate its growth plans.
Imexpharm clinches top honours in corporate annual reporting

Imexpharm clinches top honours in corporate annual reporting

Imexpharm has scored top honours in corporate governance.
Sweef Capital invests in USM Healthcare

Sweef Capital invests in USM Healthcare

Sweef Capital has announced that the second investment from its Southeast Asia Women’s Economic Empowerment Fund will go to USM Healthcare in Vietnam.
Medtronic at forefront of transforming Vietnam’s healthcare

Medtronic at forefront of transforming Vietnam’s healthcare

Vietnam’s healthcare industry has undergone drastic changes in recent years. More innovations in medical technology, pharmaceuticals, and treatment approaches have been developed to transform patient care and outcomes.
|< < 1 2 3 4 > >|